A new study, published in PLoS ONE, could potentially contribute to a more informed understanding of the mechanism of rheumatoid arthritis (RA) and could have an impact on the strategy taken for future clinical trials on the disease. RA is a chronic and disabling autoimmune disease and the symptoms experienced, such as, inflammation, swelling around the joints affected and impaired motion can vary between individuals. According to Arthritis Research UK, RA is the second most common form of arthritis in the UK and the Arthritis Foundation states that RA is a disease affecting 1.3 million Americans.
展开▼
